Morena, A., Oshima, C., Gebrim, L., Egami, M., Silva, M., Segreto, R., . . . Segreto, H. Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-BETA 1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma.
Chicago Style (17th ed.) CitationMorena, A.M.L, C.T.F Oshima, L.H Gebrim, M.I Egami, M.R.R Silva, R.A Segreto, O. Giannotti Filho, V.P.C Teixeira, and H.R.C Segreto. Early Nuclear Alterations and Immunohistochemical Expression of Ki-67, Erb-B2, Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor (TGF-BETA 1) and Integrine-linked Kinase (ILK) Two Days After Tamoxifen in Breast Carcinoma.
MLA (9th ed.) CitationMorena, A.M.L, et al. Early Nuclear Alterations and Immunohistochemical Expression of Ki-67, Erb-B2, Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor (TGF-BETA 1) and Integrine-linked Kinase (ILK) Two Days After Tamoxifen in Breast Carcinoma.


